Menarini Group e Insilico Medicine firman un acuerdo de licencia global para un nuevo inhibidor de KAT6 ...Middle East

News by : (PR Newswire) -
Menarini Group e Insilico Medicine firman un acuerdo de licencia global exclusivo para un nuevo inhibidor de KAT6 para posible tratamiento del cáncer de mama y otras indicaciones oncológicas KAT6 es un objetivo emergente en tumores de mama sensibles a hormonas y otros cánceres. La...

Hence then, the article about menarini group e insilico medicine firman un acuerdo de licencia global para un nuevo inhibidor de kat6 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Group e Insilico Medicine firman un acuerdo de licencia global para un nuevo inhibidor de KAT6 )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار